As European markets navigate the challenges of geopolitical tensions and inflationary pressures, investors continue to seek stability and growth through dividend stocks. In such a climate, selecting stocks with robust earnings growth and consistent dividend payouts can be an effective strategy for those looking to generate income while potentially mitigating volatility.
Top 10 Dividend Stocks In Europe
|
Name |
Dividend Yield |
Dividend Rating |
|
Zurich Insurance Group (SWX:ZURN) |
4.24% |
★★★★★★ |
|
Zinzino (OM:ZZ B) |
4.50% |
★★★★★★ |
|
Teleperformance (ENXTPA:TEP) |
5.96% |
★★★★★★ |
|
Swiss Re (SWX:SREN) |
5.07% |
★★★★★★ |
|
Rubis (ENXTPA:RUI) |
5.90% |
★★★★★★ |
|
Hannover Rück (XTRA:HNR1) |
5.17% |
★★★★★★ |
|
EFG International (SWX:EFGN) |
3.75% |
★★★★★☆ |
|
DKSH Holding (SWX:DKSH) |
4.05% |
★★★★★★ |
|
Cembra Money Bank (SWX:CMBN) |
4.47% |
★★★★★★ |
|
Banque Cantonale Vaudoise (SWX:BCVN) |
3.76% |
★★★★★★ |
Click here to see the full list of 201 stocks from our Top European Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Bureau Veritas SA is a company that offers laboratory testing, inspection, and certification services with a market cap of €11.78 billion.
Operations: Bureau Veritas SA generates revenue from various segments, including Buildings & Infrastructure (€1.99 billion), Industry (€1.37 billion), Agri-Food & Commodities (€1.16 billion), Consumer Products Services (€802.40 million), Certification (€571.70 million), and Marine & Offshore (€557.90 million).
Dividend Yield: 3.5%
Bureau Veritas has a mixed dividend profile, with its dividends covered by earnings (payout ratio: 69.7%) and cash flows (cash payout ratio: 47.5%). However, the company’s dividend yield of 3.47% is below the top tier in France, and its dividend history has been volatile over the past decade. Recent strategic initiatives, such as an AI systems audit launch and a €200 million share buyback program, highlight growth potential but come amid high debt levels.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Equasens Société anonyme offers healthcare IT solutions across Europe and has a market cap of €559.91 million.
Operations: Equasens Société anonyme generates revenue through its segments, with Pharmagest contributing €167.36 million and Axigate Link adding €33.16 million.
Dividend Yield: 3.4%
Equasens Société anonyme offers a stable dividend profile, with a payout ratio of 51.8% indicating coverage by earnings. Despite its dividend yield of 3.36% being lower than the top tier in France, dividends have been reliable and growing over the past decade. Recent revenue growth to €61.4 million for Q1 2026 and a proposed gross dividend of €1.40 per share underscore its commitment to shareholders, though leadership changes may introduce strategic shifts.